SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,649,000 | +25.7% | 27,559 | -3.8% | 0.05% | +21.4% |
| Q1 2018 | $1,312,000 | +21.7% | 28,641 | +5.9% | 0.04% | +20.0% |
| Q4 2017 | $1,078,000 | +1.5% | 27,054 | +1.9% | 0.04% | -7.9% |
| Q3 2017 | $1,062,000 | -17.4% | 26,550 | -11.0% | 0.04% | -24.0% |
| Q2 2017 | $1,285,000 | +17.5% | 29,825 | -14.6% | 0.05% | +11.1% |
| Q1 2017 | $1,094,000 | +10.4% | 34,940 | -11.0% | 0.04% | 0.0% |
| Q4 2016 | $991,000 | -13.1% | 39,247 | -14.9% | 0.04% | -18.2% |
| Q3 2016 | $1,140,000 | +5.9% | 46,105 | -12.8% | 0.06% | -3.5% |
| Q2 2016 | $1,076,000 | +36.7% | 52,844 | +2.5% | 0.06% | +26.7% |
| Q1 2016 | $787,000 | – | 51,580 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |